High throughput cell-based assay kits

• US 20010055776A1
• Filed: 06/18/2001
• Published: 12/27/2001
• Est. Priority Date: 02/11/2000
• Status: Abandoned Application

• Current Assignee: Greenwalt, Dale
• Original Assignee: Greenwalt, Dale
• Inventors: Greenwalt, Dale
• Application Number:
  US09/882,023
• Publication Number:
  US 20010055776A1
• Time in Patent Office: Days
• US Class Current: 435/7.1
• CPC Class Codes: G01N 2458/40 Rare earth chelates
• CPC Class Codes: G01N 33/582 with fluorescent label

Abstract

A new assay is described that incorporates the time saving features of a lanthanide chelate-conjugated ligand and a filter plate on which cells can be both cultured and washed in situ with vacuum assist. Loss of cells during washing steps is significantly curtailed through the use of the cell-culture-compatible filter plates, and the high endogenous fluorescence backgrounds characteristic of cell-based assays is avoided by use of time-resolved fluorescence. The assay described herein permits the screening of large libraries of compounds and/or recombinant proteins for either toxicity or stimulation of differentiation.

Claims

1. A method of detecting a marker protein of a cell, comprising the steps of:

(a) culturing the cell on a filter plate, wherein the filter plate has;

(i) a low background phosphorescence; and

(ii) pores which permit the cell to be cultured on the filter plate and to be washed in situ;

(b) contacting the cell with a reagent comprising;

(i) a ligand which specifically binds to the marker protein; and

(ii) a lanthanide chelate comprising a lanthanide ion and a chelating agent, wherein the chelating agent is bound to the ligand;

(c) washing the cell with vacuum assist to remove reagent which is not bound to the marker protein to provide a washed cell; and

(d) observing the washed cell for a sufficient time to detect fluorescence associated with the lanthanide ion which is at least two-fold greater relative to any background fluorescence, wherein detection of the fluorescence associated with the lanthanide ion indicates the presence of the marker protein.

2. The method of

claim 1

wherein the reagent further comprises a β

-diketone.

3. The method of

claim 1

further comprising the step of contacting the washed cell with a solution sufficient to dissociate the lanthanide ion from the chelating agent, wherein the solution comprises a β

-diketone.

4. The method of

claim 1

wherein the fluorescence associated with the lanthanide ion is at least about five-fold greater.

5. The method of

claim 1

wherein the fluorescence associated with the lanthanide ion is at least about ten-fold greater.

6. The method of

claim 1

wherein the marker protein is a cell-specific marker protein.

7. The method of

claim 1

wherein the marker protein is a cell-surface protein.

8. The method of

claim 7

wherein the cell surface protein is selected from the group consisting of glycophorin A, CD11b, CD19, CD34, CD36, CD41, gpIIbIIIa, and an erythropoietin receptor.

9. The method of

claim 1

wherein the marker protein is an intracellular protein.

10. The method of

claim 9

wherein the intracellular protein is selected from the group consisting of hemoglobin A, a cytokine, a cytokeratin, actin, a signal transduction molecule, tartrate-resistant acid phosphatase, von Willebrand factor, GFAP, MAP2, beta tubulin III, and nestin.

11. The method of

claim 1

wherein the cell is contacted with at least two ligands, wherein each ligand specifically binds to a different marker protein of the cell.

12. The method of

claim 1

wherein the lanthanide chelate is a Europium chelate.

13. The method of

claim 1

wherein the pores of the filter plate are 3.0 82 m or below in average diameter.

14. The method of

claim 13

wherein the pores of the filter plate are at least about 0.4 μ

m in average diameter.

15. The method of

claim 1

wherein the filter plate comprises at least 96 discrete wells.

16. The method of

claim 1

wherein the filter plate comprises at least 384 discrete wells.

17. The method of

claim 1

wherein the cell is a progenitor cell.

18. The method of

claim 17

wherein the progenitor cell is selected from the group consisting of an embryonic stem cell, an erythroid progenitor cell, and a neural progenitor cell.

19. The method of

claim 1

wherein the filter plate is a polycarbonate filter plate.

20. The method of

claim 1

wherein the fluorescence associated with the lanthanide chelate is detected by time-resolved fluorimetry.

21. The method of

claim 1

wherein the cell is cultured in the presence of a test compound, and wherein detection of a greater or lesser amount of fluorescence associated with the lanthanide ion in the presence of the test compound relative to the absence of the test compound identifies the test compound as having the ability to affect expression of the marker protein.

22. The method of

claim 21

, further comprising the steps of:

measuring a first fluorescence associated with a lanthanide ion in the presence of the test compound;

measuring a second fluorescence associated with the lanthanide ion in the absence of the test compound; and

subtracting the second fluorescence from the first fluorescence to obtain the difference between the fluorescences.

28. The test kit of

claim 27

further comprising instructions for the method of

claim 1

.

42. A test kit, comprising:

(a) a polycarbonate filter plate having an average pore size of about 00.4 μ

m;

(b) a reagent comprising;

(i) an antibody which specifically binds to a marker protein of an erythroid progenitor cell; and

(ii) a Europium chelate comprising a Europium ion and a chelating agent, wherein the chelating agent is bound to the antibody;

(c) a solution comprising a β

-diketone and sufficient to dissociate the Europium ion from the chelating agent; and

(d) instructions for the method of

claim 1

.

43. The test kit of

claim 42

further comprising a CD36⁺ erythroid progenitor cell.

23. A method of detecting a marker protein of a cell, comprising the steps of:

(a) culturing the cell on a filter plate, wherein the filter plate has;

(i) a low background phosphorescence; and

(ii) pores which permit the cell to be cultured on the filter plate and to be washed in situ;

(b) contacting the cell with a first ligand which specifically binds to the marker protein;

(c) washing the cell with vacuum assist to remove first ligand which is not specifically bound to the marker protein;

(d) contacting the cell with a reagent comprising;

(i) a second ligand which specifically binds to the first ligand; and

(ii) a lanthanide chelate comprising a lanthanide ion and a chelating agent, wherein the chelating agent is bound to the second ligand;

(e) washing the cell with vacuum assist to remove reagent which is not specifically bound to the first ligand to provide a washed cell; and

(f) observing the washed cell for a sufficient time to detect fluorescence associated with the lanthanide ion which is at least two-fold greater relative to any background fluorescence, wherein detection of the fluorescence associated with the lanthanide ion indicates the presence of the marker protein.

24. The method of

claim 23

wherein either:

(1) the first ligand comprises a biotin moiety and the second ligand comprises a moiety selected from the group consisting of avidin and streptavidin;

(2) the first ligand comprises a moiety selected from the group consisting of avidin and streptavidin and the second ligand comprises a biotin moiety;

or

(3) the first ligand is a primary antibody and the second ligand is a secondary antibody.

25. The method of

claim 23

wherein the cell is cultured in the presence of a test compound, and wherein detection of a greater or lesser amount of fluorescence associated with the lanthanide ion in the presence of the test compound relative to the absence of the test compound identifies the test compound as having the ability to affect expression of the marker protein.

26. The method of

claim 23

, further comprising the steps of:

measuring a first fluorescence associated with a lanthanide ion in the presence of the test compound;

measuring a second fluorescence associated with the lanthanide ion in the absence of the test compound; and

subtracting the second fluorescence from the first fluorescence to obtain the difference between the fluorescences.

29. The test kit of

claim 27

further comprising instructions for the method of

claim 23

.

27. A test kit, comprising:

(a) a ligand for a marker protein;

(b) a source of lanthanide ion; and

(c) a filter plate suitable for culturing cells, having;

(1) a low background phosphorescence; and

(2) pores which permit cells to be cultured on the filter plate and to be washed in situ.

30. The test kit of

claim 27

further comprising a cell which can express the marker protein.

31. The test kit of

claim 30

, wherein the cell is a progenitor cell.

32. The test kit of

claim 31

, wherein the progenitor cell is selected from the group consisting of an embryonic stem cell, an erythroid progenitor cell, and a neural progenitor cell.

33. The test kit of

claim 27

, wherein the lanthanide is Europium.

34. The test kit of

claim 27

wherein the filter plate comprises at least 96 discrete wells.

35. The test kit of

claim 34

wherein the filter plate comprises at least 384 discrete wells.

36. The test kit of

claim 27

wherein the marker protein is a cell-specific marker protein.

37. The test kit of

claim 36

wherein the marker protein is a cell-surface marker protein.

38. The test kit of

claim 37

wherein the cell-surface marker protein is selected from the group consisting of glycophorin A, CD11b, CD19, CD34, CD36, CD41, gpIIbIIIa, and an erythropoietin receptor.

39. The test kit of

claim 36

wherein the marker protein is an intracellular protein.

40. The test kit of

claim 39

wherein the intracellular protein is selected from the group consisting of hemoglobin A, a cytokine, a cytokeratin, actin, a signal transduction molecule, tartrate-resistant acid phosphatase, von Willebrand factor, GFAP, MAP2, beta tubulin III, and nestin.

41. The test kit of

claim 27

wherein the source of lanthanide ion is selected from the group consisting of a lanthanide chelate, a reagent comprising a ligand bound to a lanthanide chelate, and a reagent comprising a lanthanide chelate and a β

-diketone.